About tela bio inc - TELA
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
TELA At a Glance
TELA Bio, Inc.
1 Great Valley Parkway
Malvern, Pennsylvania 19355
| Phone | 1-484-320-2930 | Revenue | 80.28M | |
| Industry | Medical Specialties | Net Income | -38,831,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 15.837% | |
| Fiscal Year-end | 12 / 2026 | Employees | 218 | |
| View SEC Filings |
TELA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.69 |
| Price to Book Ratio | 8.325 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.90 |
| Enterprise Value to Sales | 0.775 |
| Total Debt to Enterprise Value | 0.927 |
TELA Efficiency
| Revenue/Employee | 368,233.945 |
| Income Per Employee | -178,123.853 |
| Receivables Turnover | 6.719 |
| Total Asset Turnover | 0.948 |
TELA Liquidity
| Current Ratio | 4.205 |
| Quick Ratio | 3.592 |
| Cash Ratio | 2.829 |
TELA Profitability
| Gross Margin | 67.694 |
| Operating Margin | -42.049 |
| Pretax Margin | -48.086 |
| Net Margin | -48.372 |
| Return on Assets | -45.858 |
| Return on Equity | -223.353 |
| Return on Total Capital | -60.705 |
| Return on Invested Capital | -57.778 |
TELA Capital Structure
| Total Debt to Total Equity | 913.258 |
| Total Debt to Total Capital | 90.131 |
| Total Debt to Total Assets | 70.287 |
| Long-Term Debt to Equity | 904.958 |
| Long-Term Debt to Total Capital | 89.312 |